What is OncoLens worth?
$54.0Mlast known valuation
Free account
More of OncoLens with a free account
- ·Watch OncoLens: the Monday email on marks, rounds and moves
OncoLens funding history
No rounds on record
No funding rounds for OncoLens are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Pro members can request priority coverage with a 48-hour turnaround.
OncoLens valuation
OncoLens's last known valuation is $54 million. The figure stands until a priced round, a secondary trade or an institutional fund mark prices the stock again.
How OncoLens's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For OncoLens, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →
Frequently asked about OncoLens
- What is OncoLens worth?
- OncoLens's last known valuation is $54.0M.
- How much has OncoLens raised?
- OncoLens has raised $22.9M in total funding across its recorded rounds.